Skip to main content

Rapid pace of interceptor and precision-guided weapons use worries Trump admin.

▶ Watch Video: U.S. bolsters military in Middle East amid 12th night of strikes on Iran

Washington — The rapid pace at which the U.S. is expending some of its most advanced air-defense interceptors and precision-guided weapons in the Middle East is a point of great tension inside the Trump administration as President Trump’s war with Iran ratchets up again, according to U.S. military and intelligence officials familiar with internal assessments. And it’s raising broader concerns about America’s readiness for a potential conflict in the Indo-Pacific. 

The dwindling stockpiles of defensive interceptors and long-range missiles have become a pressure point for top military and civilian leaders who are weighing the demands of the war with Iran against maintaining readiness to deter other adversaries, including China. 

The U.S. officials, who spoke to CBS News on condition of anonymity given the sensitivity of the topic, said the U.S. cannot sustain the rate at which it expended precision munitions early in the campaign against Iran.

The defense industrial base is not equipped to produce missiles rapidly enough to replenish munitions that have been fired or transferred to U.S. Central Command, which is overseeing the conflict, leaving inventories under mounting pressure even as military operations continue. 

Interceptors are in heavy use to defend U.S. interests in the Gulf states, which house U.S. troops and are being targeted by Iranian drones and missiles.

One partner country told CBS News there is a need for a pause in fighting, particularly given the intensity of Iranian strikes that have been battering Kuwait and Bahrain. Kuwait said earlier this week that Iran struck its infrastructure, damaging electricity and desalination plants

In an interview last month with “Face the Nation with Margaret Brennan,” Defense Secretary Pete Hegseth denied that there was any crisis with the stockpiles. He conceded that some munitions may take more time to produce than others, but he told Brennan, “We’ve got lots of them, we’re building more than ever before.”

“Our stockpiles are strong, and they will only get stronger in the future,” Hegseth said.

But U.S. commanders have increasingly been shifting toward using more GPS-guided bombs fitted with Joint Direct Attack Munitions, or JDAM, guidance kits, along with Small Diameter Bombs, which are precision-glide weapons that can attack fixed targets at shorter ranges and can also be used in lieu of long-range standoff weapons. 

Earlier in the conflict, U.S. forces frequently employed long-range cruise missiles such as the Joint Air-to-Surface Standoff Missile, known as JASSM, and the Tomahawk Land Attack Missile. Those weapons remain in the arsenal, officials said, but are being used more sparingly. 

In April, Adm. Samuel Paparo, the head of U.S. Indo-Pacific Command, told lawmakers on Capitol Hill that scaling up output of high-end systems such as the Tomahawk cruise missile or JASSM could take years, as defense companies work on expanding production lines. 

“I think it will take one to two years for them to scale,” said Paparo, whose responsibilities include preparing for any potential conflict in the Pacific region, including with China. “It won’t be soon enough. There are finite limits to the magazine, and I have all the faith in the world that they’re being employed judiciously.” 

Following the collapse of the ceasefire earlier this month, U.S. strikes have focused on targets closer to Iran’s coastline, reducing the need for aircraft to penetrate deeper into Iranian territory, where they would face denser air-defense networks and a greater threat from surface-to-air missiles. 

The U.S. officials told CBS News there are limited inventories of the Army Tactical Missile System, or ATACMS, the long-range missiles fired from the High Mobility Artillery Rocket System, known as HIMARS, a truck-mounted launcher capable of firing precision rockets and missiles. 

Concerns over certain munition inventories are not new. The Biden administration delayed giving ATACMS to Ukraine in part because drawing from those inventories could undermine U.S. military readiness, CBS News previously reported. 

The U.S. has comparatively healthier supplies of the shorter-range Guided Multiple Launch Rocket System, or GMLRS, which is also fired from the HIMARS launcher, the officials told CBS News, allowing commanders greater flexibility for targets within its range.

The most pressing concern involves air-defense interceptors, used to defend against cruise and ballistic missiles, aircraft and lethal drones, several sources said.

The U.S. has expended large numbers of Patriot and Terminal High Altitude Area Defense, or THAAD, interceptors to defend against both ballistic missiles and drones, consuming inventories faster than industry can replace them.

To support operations in the Middle East, the Pentagon has shifted interceptor inventories from other regions, including stocks that had been prepositioned for the Indo-Pacific. Those transfers have left other combatant commands operating with thinner margins than military planners consider ideal, particularly as the U.S. seeks to deter Chinese military action around Taiwan and reassure allies across the Pacific. 

Asked for comment, chief Pentagon spokesman Sean Parnell told CBS News: “America’s military is the most powerful in the world and has everything it needs to execute at the time and place of the President’s choosing. We have executed multiple successful operations across combatant commands while ensuring the U.S. military possesses a deep arsenal of capabilities to protect our people and our interests.”

In 2022, Elbridge Colby, who was a defense official during the first Trump administration and is now the undersecretary for policy at the Pentagon, summed up the choices confronting an American military stretched across the globe: “A missile used in Europe can’t be used in Asia,” he wrote in Time magazine.

He was commenting on the use of U.S. munitions in the war in Ukraine. But the latest stage of the American campaign against Iran has brought the same strategic dilemma into renewed focus.

A year later, Colby argued that weapons that could be useful for defeating a Chinese attack along the first island chain — a string of islands off China’s coast extending from Japan, through Taiwan and the Philippines — should be reserved for that purpose. The concerns of U.S. officials about current stockpiles involve some of those same weapons.

During the ceasefire pause, a Center for Strategic and International Studies report said more than 1,000 Tomahawks and 1,100 JASSMs had been used and that replacement timelines were approaching four years. It said that supplies of air-defense interceptors are under even greater strain, as the U.S. burns through a significant share of prewar inventories of THAAD, SM-3 missiles and Patriots. These weapons face production timelines of up to five years. 

Taken together, the numbers suggest that the central problem is not simply cost but time. Many of the weapons being fired in weeks or months cannot be replaced for years

What to know about Candida auris, a fungus contaminating healthcare spaces

(CNN) — Cases of Candida auris, a fungus found in healthcare facilities, are rising rapidly this year, the US Centers for Disease Control and Prevention says.As of July 25, 3,437 clinical cases in 27 states have been reported, CDC data shows. The agency recorded 4,290 clinical cases in all of last year.C. auris is primarily a concern for people who are hospitalized. The total number of clinical cases has been increasing since its detection in the US in 2016, the CDC says. The rate has slowed in recent years, but it still remains a “critical public health threat.”What is Candida auris, and how does it spread?Candida auris is a yeast, a specific type of fungus, that spreads through contact with contaminated objects and people, according to Dr. Graham Snyder, medical director of infection prevention and hospital epidemiology at University of Pittsburgh Medical Center.A common characteristic, Snyder said, is its ability to spread and remain in healthcare settings, including nursing facilities and hospitals, as it can resist certain cleaning products. It more seriously affects people who have underlying conditions.“We quickly learned that Candida auris is very good at sticking around in the environment — and that’s not true for all types of pathogens or germs that may be spread through the environment — so we pay extra special attention when we know somebody has Candida auris to making sure that we clean and disinfect the environment,” Snyder said.The first case of C. auris was detected in Japan in 2009; the first case in the United States was detected in 2016, according to the CDC. The agency characterizes C. auris as an “urgent threat,” as it is often multidrug-resistant, meaning certain strains can be resistant to all three classes of antifungal medications used to treat fungal infections.What happens when people get it?There are two ways people can have C. auris, said Dr. Scott Roberts, an associate professor of infection prevention at Yale University. The first, colonization, occurs when the fungi appear on a person’s skin, and it’s asymptomatic most of the time. The second, infection, happens when it enters the body through a break in the skin.C. auris can be detected via a swab of the armpit or groin area.“Most of the time, the infections occur through bloodstream infection. There’s some entry into the skin somewhere; maybe your immune system’s not as good as it should be. You can’t fight it off, and you lead to a big infection,” Roberts said.Although this year’s case count may sound alarming, Dr. Nitipong Permpalung, director of mycology research at Johns Hopkins University, noted that there has also been an increase in screening that differentiates between those who are colonized with C. auris and those who are infected, which could account for some of the rising numbers.“We need to understand that ‘OK, this is a positive screening test, and this is through clinical case, and go from there,’ but I understand the concern. But we need to get some more data, and we need to work on the research in this area to improve the care,” Permpalung said.Dr. Ilan Schwartz, an associate professor of medicine at Duke University, said the fungi can cause symptoms like fever, low blood pressure or a high heart rate, as well as a dangerous condition called sepsis, when it enters the bloodstream. Because it spreads more often in healthcare settings, Schwartz said, it primarily affects people who have other health conditions.Like many germs that can be potentially deadly “in the right circumstance,” Schwartz said, infections can become serious and can be deadly in vulnerable patients, such as those undergoing chemotherapy, recovering from surgery or taking antibiotics.“Generally, these are going to be in patients who are already hospitalized and who are being monitored, and so the healthcare team should be well aware already if patients are showing signs of a general infection, so I don’t think that it’s something individuals need to be vigilant about,” Schwartz said.Awareness at the forefrontRoberts said people who are hospitalized or living in other medical settings should watch for symptoms of sepsis, including fever, high heart rate and low blood pressure.The most important thing people can do if their doctor detects the fungi, Roberts said, is to notify those they live with or those who are around them in a care facility. In addition, focus on washing hands and not sharing medical equipment before it is disinfected.Although C. auris continues to spread, hospitals and nursing homes can screen people to identify the fungi and potentially isolate them as an infection prevention practice, Roberts said.“I just have low confidence every facility can do that, or even right now we don’t even know how big a problem it is because a lot of places are not testing for this or don’t have the lab capability to even identify it,” Roberts said.Roberts noted that once the fungi has colonized a person, treatment generally focuses on any symptoms that develop.“There’s unfortunately not much to do,” Roberts said. “It’s moreso just awareness that it is on the scan or that it is there in that room.”The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story